These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8630283)

  • 41. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
    Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
    Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
    Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
    Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
    Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J; Li R; Li A
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Philipp M; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Clin Exp Med; 2003 Feb; 2(4):185-91. PubMed ID: 12624710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
    Carney DN; Marangos PJ; Ihde DC; Bunn PA; Cohen MH; Minna JD; Gazdar AF
    Lancet; 1982 Mar; 1(8272):583-5. PubMed ID: 6121182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
    Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
    Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS.
    Torsetnes SB; Levernæs MS; Broughton MN; Paus E; Halvorsen TG; Reubsaet L
    Anal Chem; 2014 Jul; 86(14):6983-92. PubMed ID: 24945626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP).
    Yoshimura T; Fujita K; Kinukawa H; Matsuoka Y; Patil RD; Beligere GS; Chan SS; Dowell BL; Sokoll L; Elliott D; Chan DW; Scheuer C; Hofmann K; Stieber P; Sakurai Y; Iizuka M; Saegusa H; Yamaguchi K
    Clin Chem Lab Med; 2009; 47(12):1557-63. PubMed ID: 19824798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
    Holdenrieder S; Von Pawel J; Duell T; Feldmann K; Raith H; Schollen A; Nagel D; Stieber P
    Anticancer Res; 2010 May; 30(5):1855-62. PubMed ID: 20592392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma.
    Cheng Y; He J; Zhang L; Chen X; Ou S
    J Int Med Res; 2020 Apr; 48(4):300060519882802. PubMed ID: 31856626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy.
    Li M; Han D; Wang W; Zhang Y; Li D; Dai C; Qian L; Lin W
    Oncol Lett; 2020 Dec; 20(6):301. PubMed ID: 33101495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
    Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
    Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
    Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
    Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-6 and VEGF in small cell lung cancer patients.
    Wójcik E; Jakubowicz J; Skotnicki P; Sas-Korczyńska B; Kulpa JK
    Anticancer Res; 2010 May; 30(5):1773-8. PubMed ID: 20592377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.